| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.0021 | 1 |